CollPlant Biotechnologies (CLGN) Current Assets (2018 - 2025)

CollPlant Biotechnologies' Current Assets history spans 8 years, with the latest figure at $6.7 million for Q4 2025.

  • For Q4 2025, Current Assets fell 48.81% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $6.7 million, down 48.81%, while the annual FY2025 figure was $6.7 million, 48.81% down from the prior year.
  • Current Assets reached $6.7 million in Q4 2025 per CLGN's latest filing, down from $13.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $45.1 million in Q4 2021 to a low of $6.7 million in Q4 2025.
  • Average Current Assets over 5 years is $24.9 million, with a median of $28.0 million recorded in 2023.
  • Peak YoY movement for Current Assets: skyrocketed 694.34% in 2021, then plummeted 52.97% in 2024.
  • A 5-year view of Current Assets shows it stood at $45.1 million in 2021, then dropped by 29.78% to $31.7 million in 2022, then decreased by 11.49% to $28.0 million in 2023, then tumbled by 52.97% to $13.2 million in 2024, then plummeted by 48.81% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Current Assets are $6.7 million (Q4 2025), $13.2 million (Q4 2024), and $28.0 million (Q4 2023).